首页|1990-2021年中国及分省贫血疾病负担分析

1990-2021年中国及分省贫血疾病负担分析

扫码查看
目的 分析1990-2021年中国人群贫血疾病负担及其变化情况,为制定贫血预防控制策略措施提供依据.方法 利用2021年全球疾病负担(GBD)中国分省研究结果,分析2021年中国贫血疾病负担现状.采用SAS 9.4和R 4.4.0软件计算贫血患病数、患病率、标化患病率、伤残寿命损失年(YLD)、YLD率、标化YLD率及各项指标的变化幅度.采用Joinpoint4.8.0.1软件计算平均年度变化百分比(AAPC).结果 2021年中国贫血患病数和YLD分别为13 626.31万例和301.59万人年,较1990年分别下降了 36.98%和44.30%.1990-2021年贫血标化患病率和标化YLD率总体呈下降趋势(P<0.01),女性高于男性.标化患病率从1990年的19 013.34/10万降低至2021年的8 913.09/10万,降幅为53.12%,下降趋势有统计学意义(AAPC=-2.42%,P<0.01).标化YLD率从1990年的494.04/10万降低至2021年的200.83/10万,降幅为59.35%,下降趋势有统计学意义(AAPC=-2.86%,P<0.01).2021年,男性<5岁人群患病数最多,为395.20万例,女性在30~34岁年龄组人群患病数最多,为972.10万例.随着年龄的增加,男、女性贫血患病率均有所增加,但女性人群在20~49岁年龄组明显增高.2021年贫血标化患病率最高的3个省(自治区、直辖市、特别行政区)分别为西藏(14 839.08/10万)、新疆(11 860.15/10万)和青海(11 730.70/10万),标化YLD率较高的3个省(自治区、直辖市、特别行政区)分别为西藏(429.68/10万)、青海(316.75/10万)和新疆(306.52/10万).与1990年相比,全国33个省级行政单位(含特别行政区)贫血的标化患病率和标化YLD率均有所下降.结论 1990-2021年中国贫血疾病负担呈下降趋势,女性高于男性,各省贫血标化患病率和标化YLD率均有所下降,但仍存在差异.
Disease burden of anemia in China and its provinces from 1990 to 2021
Objective To analyze the burden of anemia and its changes in the Chinese population from 1990 to 2021,and provide the basis for formulating strategies and measures of anemia prevention and control.Methods The results of the 2021 Global Burden of Disease(GBD)for Chinese provinces study were used to analyze the anemia burden of China in 2021.The SAS 9.4 software and R 4.4.0 software were used to calculate the prevalence number,prevalence rate,age-standardized prevalence rate,years lived with disability(YLD),YLD rate and age-standardized YLD rate of anemia.The average annual percent change(AAPC)was calculated using Joinpoint 4.8.0.1 software.Results In 2021,the number of prevalence and YLD of anemia in China were 136.26 million and 3.02 million person-years,which decreased by 36.98%and 44.30%as compared with 1990,respectively.The age-standardized prevalence rate and age-standardized YLD rate of anemia showed a downward trend from 1990 to 2021(P<0.01),the anemia burden of female was higher than that of male.The age-standardized prevalence rate(19 013.34/105)in 1990 decreased to the age-standardized prevalence rate(8 913.09/105)in 2021,the drop was 53.12%,AAPC=-2.42%(P<0.01).The age-standardized YLD rate(494.04/105)in 1990 decreased to 200.83/105 in 2021,the drop was 59.35%,AAPC=-2.86%(P<0.05).In 2021,the anemia number(395.20 ten thousand cases)of male children<5 years old was the greatest;the anemia number(972.10 ten thousand cases)of females(30-34 years old)was the greatest.The prevalence rates of anemia in males and females increased with age,but the prevalence rate of anemia in females(20-49 years old)significantly elevated.In 2021,3 top provinces with the highest age-standardized prevalence rate of anemia were Xizang(14 839.08/105),Xinjiang(11 860.15/105)and Qinghai(11 730.70/105),respectively;3 top provinces with the highest age-standardized YLD rate of anemia were Xizang(429.68/105),Qinghai(316.75/105)and Xinjiang(306.52/105),respectively.As compared with 1990,the age-standardized prevalence rates and age-standardized YLD rates of anemia in 33 provinces all decreased.Conclusion From 1990 to 2021,the disease burden of anemia in China showed the downtrend,the anemia burden of female was higher than that of male.The age-standardized prevalence rate and age-standardized YLD rate in all provinces decreased,but there was differences.

AnemiaPrevalence rateYears lived with disabilityDisease burden

龙政、殷鹏、王黎君、周脉耕、冀冰心

展开 >

首都医科大学宣武医院医务处,北京 100053

中国疾病预防控制中心慢性非传染性疾病预防控制中心生命登记与死因监测室

中国疾病预防控制中心慢性非传染性疾病预防控制中心

首都医科大学宣武医院血液科,北京 100053

展开 >

贫血 患病率 伤残寿命损失年 疾病负担

2024

中国慢性病预防与控制
中华预防医学会,天津市疾病预防控制中心

中国慢性病预防与控制

CSTPCD北大核心
影响因子:1.093
ISSN:1004-6194
年,卷(期):2024.32(12)